Find a TenderPast planning notice
Published 9 Jun 2023, 10:24 BST

Official UK procurement notice

Licensed Bulk Medicines · UK public procurement notice

Official notice

Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)

Goods
Planned pipeline value£42,317,737pipeline notice, not a live tender
Tender notice expected 1 Jan 2025from the planned procurement notice

What is being bought

Published requirement description

We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products.

Estimated value in the Wales market of this list is £42,317,736.61 p/a at current prices.

The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered.

Drug,Strength,Proposed Vial Size

ARSENIC TRIOXIDE,1mg/mL,

AZACITIDINE,25mg/mL,500mL

BEVACIZUMAB,25mg/mL,100mL - 250mL

BORTEZOMIB,2.5mg/mL,50mL

CALCIUM FOLINATE,10mg/mL,1000mL

CARBOPLATIN,10mg/mL,1000mL

CETUXIMAB,5mg/mL,250m – 500mL

CISPLATIN,1mg/mL,500mL - 1000mL

CYCLOPHOSPHAMIDE,20mg/mL,500mL

CYTARABINE,100mg/mL or 20mg/mL,250mL

DARATUMUMAB,20mg/mL,100mL – 250mL

DOCETAXEL,20mg/mL,250mL - 500mL

DOXORUBICIN,2mg/mL,1000mL

EPIRUBICIN,2mg/mL,1000mL

ETOPOSIDE,20mg/mL,500mL

FLUCLOXACILLIN,,3000mL

FLUOROURACIL,50mg/mL or 25mg /mL,250-500mL

INFLIXIMAB,10mg/mL,500mL - 1000mL

IRINOTECAN,20mg/mL,1000mL

NIVOLUMAB,10mg/mL,250mL

OXALIPLATIN,5mg/mL,500mL-1000mL

PACLITAXEL,6mg/mL,1000mL

PEMBROLIZUMAB,25mg/mL,100mL – 250mL

PEMETREXED,25mg/mL,100mL – 250mL

PIPERACILLIN & TAZOBACTAM,,3000mL

RITUXIMAB,10mg/mL,500mL

TOCILIZUMAB,20mg/mL,250mL

TRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mL

VEDOLIZUMAB,60mg/mL,250mL

VITLIPID N INFANT,N/A,250mL

Please inform us via the contact information above if you are able to provide these products.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Past planning notice
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
9 Jun 2023, 10:24 BST
Last source update
9 Jun 2023, 10:24 BST
FTS notice number
2023/S 000-016383
Classification (CPV)
Pharmaceutical products
Delivery area
Wales (UKL)
Official registry OCID
ocds-h6vhtk-03d4f5 Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

9 Jun 2023 → 1 Jan 2025 · 2 dates
  1. Notice published
    9 Jun 2023, 10:24 BST
  2. Tender notice expected
    1 Jan 2025

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts)

Contracting authorityNHS & healthcareBody governed by public lawHealth Procurement Services, 4th Floor, Companies House, Crown Way, Cardiff, Wales, CF14 3UBContact email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.